Breaking News on Pharmaceutical Technology

Product innovations > Research Study

Fill form to download now!

*
*
*
*
*
*
*
*
*

YesNo

Please note that any information that you supply is protected by our Privacy Policy.
Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.

XP500: Optimized, Evolutionary ODT Performance

Published:10-Apr-2009
Format:PDF file
Type:Research Study

XP500 is the latest development in the constant improvement of ODT dosage forms. The formulator is required to produce a tablet which is rapidly disintegrating, possesses superior organoleptic characteristics, and is sufficiently durable. The wide functioning characteristics of this new delivery system allow a formulator to make a high dosage (500mg) formula that dissolves in less than 30 seconds.